SOLARA Aive Pharma Sciences August 13, 2019 The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001 Scrip Code: 541540 Dear Sir/ Madam, Sub: Outcome of Board Meeting mmunition d· Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700, 22207500 Fax : +91 44 22350278 The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai- 400 051 Scrip Code: SOLARA Pursuant to Regulation 33 of SEBT (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Board of Directors at their meeting held today i.e., on August 13, 2019 have approved the unaudited financial results (standalone and consolidated) of the Company r the quarter ended June 30, 2019. A copy of the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 20 l 9 along with the Limited Review Report by the auditors and the press release on the same is attached. The Board Meeting commenced at I 0.30 a.m. and concluded at 11 :50 a.m. We request you to take the same on record. Thanking you, ��Company Secretary Encl.: as above Solara Active Pharma Sciences Limited - C: L24230MH2017PLC291636 GD. OFF : 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India / Tel : 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Communication Address· Solara Active Pharma Sciences Limited
Batra Centre
No. 28. Sardar Patel Road. Post Box 2630
Guindy. Chennai - 600 032. India
Tel : +91 44 43446700, 22207500
Fax : +91 44 22350278
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai- 400 051
Scrip Code: SOLARA
Pursuant to Regulation 33 of SEBT (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Board of Directors at their meeting held today i.e., on August 13, 2019 have approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2019.
A copy of the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 20 l 9 along with the Limited Review Report by the auditors and the press release on the same is attached.
The Board Meeting commenced at I 0.30 a.m. and concluded at 11 :50 a.m.
We request you to take the same on record.
Thanking you,
��L---j Company Secretary
Encl.: as above
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
REGD. OFF : 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India / Tel : 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Disclaimer: Certain statements in this document that are not historical facts are forward-looking statements. Such forward-looking statements are subject
to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that
could cause actual results to differ materially from those contemplated by the relevant forward-looking statements Solara Active Pharma Sciences Ltd will
not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking
statements to reflect subsequent events or circumstances.